INTERNATIONAL PATENT: C4 THERAPEUTICS, INC. FILES APPLICATION FOR "COMPOUNDS FOR TARGETED DEGRADATION OF PROTO-ONCOGENE TYROSINE PROTEIN KINASE RECEPTOR"

GENEVA, July 3 -- C4 THERAPEUTICS, INC. (490 Arsenal Way, Suite 120Watertown, MA 02472) filed a patent application (PCT/US2024/061513) for "COMPOUNDS FOR TARGETED DEGRADATION OF PROTO-ONCOGENE TYROSINE PROTEIN KINASE RECEPTOR" on Dec 20, 2024. With publication no. WO/2025/137605, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HENDERSON, James, A. (c/o C4 Therapeutics, Inc.490 Arsenal Way, Suite 120Watertown, MA 02472), ORSI, Douglas, L. (c/o C4 Therapeutics, Inc.490 Arsenal Way, Suite 120Watertown, MA 02472), VEITS, Gesi...